Global Metabolomics Market 2014-2018

Price :
Published : Jul-2014
No. of Pages : 86

Report Description

Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose specific diseases. A metabolome is the terminology used in metabolomics to describe the comprehensive and quantitative analysis of all the metabolites of an organism. Metabolomics is a relatively new field of omics research compared to other similar fields such as genomics, proteomics, and transcriptomics.

TechNavio’s analysts forecast the Global Metabolomics market will grow at a CAGR of 24.26 percent over the period 2013-2018.

Covered in this Report

The Global Metabolomics market can be divided into eight segments: Mass Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, High Performance Liquid Chromatography, Metabolomics-on-a-chip, Fourier-Transform Infrared Spectroscopy, Capillary Electrophoresis, and Electrochemical Array. These are the sets of methodologies and technologies that transform unstructured and structured data into meaningful and useful information processes.

TechNavio’s report, the Global Metabolomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Metabolomics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Human Metabolome Technologies Inc.
  • Metabolon Inc.

Other Prominent Vendors

  • Acadia Pharmaceuticals
  • Accelrys
  • BG Medicine
  • Biocrates Life Sciences
  • Chenomx
  • Life Technologies
  • Metabolomic Technologies
  • Nanosyn
  • PerkinElmer
  • Waters

Key Market Driver

  • Increase in Prevalence of Cancer and Diabetes
  • For a full, detailed list, view our report

Key Market Challenge

  • Quality Control Standards of Metabolic Profiling Data
  • For a full, detailed list, view our report

Key Market Trend

  • Emergence of Standards to Analyze Metabolomics Data
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation
09.1 Metabolomics Market in the Americas
09.1.1 Market Size and Forecast
09.2 Metabolomics Market in the EMEA
09.2.1 Market Size and Forecast
09.3 Metabolomics Market in the APAC
09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors

18. Key Vendor Analysis
18.1 Agilent Technologies
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Sales by Geography
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.1.9 Strengths
18.1.10 Weaknesses
18.1.11 Opportunities
18.1.12 Threats
18.2 Bio-Rad Laboratories
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2012
18.2.4 Business Segmentation by Revenue 2012 and 2011
18.2.5 Geographical Segmentation by Revenue 2012
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.2.9 Strengths
18.2.10 Weakness
18.2.11 Opportunities
18.2.12 Threats
18.3 Bruker
18.3.1 Key Facts
18.3.2 Business Overview/ Description
18.3.3 Business Segmentation
18.3.4 Business Strategy
18.3.5 Revenue Segmentation by Business /Products
18.3.6 Sales by Geographical Segmentation
18.3.7 Key Information
18.3.8 SWOT Analysis
18.3.9 Strengths
18.3.10 Weaknesses
18.3.11 Opportunities
18.3.12 Threats
18.4 Human Metabolome Technologies
18.4.1 Key Facts
18.4.2 Business Overview/ Description
18.4.3 Business Segmentation
18.4.4 Business Strategy
18.4.5 Revenue Segmentation by Business
18.4.6 Sales by Geographical Segmentation
18.4.7 Key Information
18.4.8 SWOT Analysis
18.4.9 Strengths
18.4.10 Weaknesses
18.4.11 Opportunities
18.4.12 Threats
18.5 Metabolon Inc.
18.5.1 Key Facts
18.5.2 Business Overview/Description
18.5.3 Business Segmentation
18.5.4 Business Strategy
18.5.5 Key Information
18.5.6 SWOT Analysis
18.5.7 02.2.1 Strengths
18.5.8 02.2.2 Weaknesses
18.5.9 02.2.3 Opportunities
18.5.10 02.2.4 Threats

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Metabolomics Market 2013-2018 (US$ million)
Exhibit 3: Global Metabolomics Market Segmentation by Technology
Exhibit 4: Global Metabolomics Market Segmentation by Application
Exhibit 5: Global Metabolomics Market by Geographical Segmentation 2013
Exhibit 6: Global Metabolomics market by Geographical Segmentation in 2018
Exhibit 7: Metabolomics Market in the Americas 2013-2018 (US$ million)
Exhibit 8: Metabolomics market in the EMEA region 2013-2018 (US$ million)
Exhibit 9: Metabolomics Market in the APAC region 2013-2018 (US$ million)
Exhibit 10: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
Exhibit 11: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 12: Agilent Technologies Inc.: Sales by Geography 2013
Exhibit 13: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
Exhibit 14: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
Exhibit 15: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 16: Business segments for Human Metabolome Technologies
Exhibit 17: Revenue Segmentation of Global Metabolomics Market 2014-2018 for 2013
Exhibit 18: Revenue Segmentation of Global Metabolomics Market 2014-2018 by Geography for 2013
Exhibit 19: Metabolon Inc. Business Segmentation

Press Release

TechNavio Announces the Publication of its Research Report - Global Metabolomics Market 2014-2018

TechNavio recognizes the following companies as the key players in the Global Metabolomics Market : Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., Human Metabolome Technologies Inc., Metabolon Inc. , Acadia Pharmaceuticals , Accelrys, BG Medicine, Biocrates Life Sciences, Chenomx, Life Technologies, Metabolomic Technologies , Nanosyn, PerkinElmer, Waters

Commenting on the report, an analyst from TechNavio’s team said: “The increasing amount of metabolomics data produced each year requires a standard and reproducible way to link data for enhanced flow of information. Standards such as MSI and COSMOS have been introduced to standardize metabolomics data. COSMOS is a project for metabolomics that generates large and diversified sets of analytical data. COSMOS captures and stores large volumes of data by having e-infrastructure metabolomics communities such as ELIXIR, EU-OPENSCREEN and BBMRI that develop and maintain open-source exchange formats for raw and processed data”

According to the report, the Global Metabolomics market is driven by several factors. An increase in the prevalence of cancer and diabetes worldwide is one of the major drivers of this market. Metabolite profiling has become an important diagnostic procedure for the detection and diagnosis of cancer, diabetes, and other chronic diseases.

Further, the report states that one of the major challenges in the market is the quality control standards for metabolic profiling data. The vast diversity of metabolites makes it impossible to analyze the biomolecules on a single analytical platform. Therefore, it is difficult to accumulate and store large amount of metabolomics data.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Filed in: Biotechnology
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Bioactive Material Market 2014-2018

Bioactive materials are part of the biomaterial family and are increasingly becoming popular due to their ability to react with body fluids and tissues without having a negative impact on the human health. They are extensively used as tissue replacement and tissue repair materials in surgical procedures. Bioactive materials are manufactured from materials such as ceramics, glass, glass-ceramics, and composites. The major end-users of bioactive materials are the Medical sector, followed by the Dentistry and Cosmetics sectors. Bioactive materials are commercially available in forms such as powders and nano-powders, granules, and injectable products and coatings. TechNavio's analysts forecast the Global Bioactive Material Market to grow at a CAGR of 13.30 percent over the period 2013-2018 ......
$2500

Genomics Market in the US 2014-2018

The genome is the genetic material of an individual, species or organism, which is responsible for the various functional characteristics of an individual. Genomics is an important aspect of genetics and molecular biology that focuses on the study of the structure, function, and mapping of genomes. It involves various applications in functional genomics, genome sequencing, comparative genomics, and genome analysis. A defect in genome structure or function could lead to the occurrence of disorders. Thus, genomic technologies, which identify and study defective genomes, play an important role in research, drug discovery, and disease diagnosis. These procedures require various instruments, reagents, and software for genomes sequencing and analysis. Analytical instruments such as polymerase ch......
$2500

Global Flow Cytometry Market 2014-2018

Flow cytometry is a technique of measuring the properties of cells in a fluid suspension. Flow cytometry focuses a beam of light onto a hydro dynamically focused stream of fluid. Flow cytometers can analyze thousands of particles in a short span of time. They can separate and isolate particles with specified properties. The analysis of multiple parameters of individual cells is carried out using flow cytometry. This technology is extensively used in several industries for various applications such as research, clinical trials, and diagnosis of various disorders. TechNavio's analysts forecast the Global Flow Cytometry market to grow at a CAGR of 11.23 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Gl......
$2500

Global Genomics Market 2014-2018

Genomics is the study of the genetic material or genomes of an organism. It is expected to be a strong basis for the discovery and development of diagnostic and therapeutic solutions for a range of human diseases or health conditions. Genomics is supported by three major product segments: Instruments, Consumables, and Services. The key end-users of such products include the Diagnostics market, academic and research institutions, and the Pharmaceutical industry. TechNavio's analysts forecast the Global Genomics market will grow at a CAGR of 11.21 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Genomics market for the period 2014-2018. To arrive at a ranking of the leading vendors of the market,......
$2500

Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018

Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study. It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and anal......
$2500

Global Cell Culture Market 2014-2018

Cell culture is the in vitro growth of plant or animal cells for several applications such as research, cell studies, and biopharmaceutical production. Cell culture is a crucial step in tissue engineering and vaccine production. Cell culture instruments and cell culture consumables are necessary for the in vitro production of cell lines. Some essential cell culture instruments are cell culture systems, incubators, biosafety cabinets, and pipetting instruments. These instruments maintain the optimum conditions, such as temperature and humidity, that are essential for cell growth. Cell culture consumables such as media, cell culture reagents, and sera provide the essential nutrients, minerals, and supplements for cell culture. TechNavio's analysts forecast the Global Cell Culture market w......
$2500

Global Genomics and Proteomics Analytical Instruments Market 2014-2018

Genomics is the study of the gene and its functions and proteomics is the study of the structure and functions of proteomes or sets of proteins by using molecular biology and bioinformatics tools and technology. Genomics involves the mapping of genes and DNA sequencing to understand the structure and functions of genomes. A proteome is a complete set of proteins expressed by a genome at a certain time. Proteomics primarily involves the use of molecular biology, biochemistry, and genetics to analyze proteins produced by genes through the translation process. Proteins are the primary component of all cells and are responsible for the various functional characteristics of cells. A defect in the genome or proteome structure or function could result in disorders. Thus, genomics and proteomics t......
$2500

Global Metabolomics Market 2014-2018

Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose specific diseases. A metabolome is the terminology used in metabolomics to describe the comprehensive and quantitative analysis of all the metabolites of an organism. Metabolomics is a relatively new field of omics research compared to other similar fields such as genomics, proteomics, and transcriptomics. Te......
$2500

Global Synthetic Biology Market 2014-2018

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment. TechNavio's analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018. Covered in this Report The Global Synthetic Biology market can be......
$2500

Regenerative Medicine Market in the US 2014-2018

Regenerative medicine is the branch of medicine which uses therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. This branch of medicine focuses on repairing, replacing, or regenerating the damaged cells of the body and thus represents a paradigm shift in healthcare treatment. The two main technologies used in regenerative medicine are tissue engineering and stem cell technology. TechNavio's analysts forecast the Regenerative Medicine market in the US will grow at a CAGR of 19.88 percent over the period 2013-2018. Covered in this Report The Regenerative Medicine market in the US can be divided into 11 segments: Orthopedic Tendon and Ligament, Chronic and Acute Wounds, Cardiology, Plastic and Reconstructive Surgery, O......
$3000